Nayan Pharmaceuticals Limited
About Nayan Pharmaceuticals Limited
Data last updated:
Nayan Pharmaceuticals Limited is a public limited company based in Patiala, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 November 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231PB1996PLC019085. Its GSTIN is 03AABCN2191F1ZW (Punjab).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹9.1 Lakh. It is led by directors including Shiv Shankar Srivastava and Akshay Kumar Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Deelwal Morh Distt Patiala, Punjab, India – 147001.
As per the financials filed for FY 2024, the company reported a revenue of ₹81.6 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹3.72 Lakh (net margin -4.6%) and EBITDA of -₹73,589 (EBITDA margin -0.9%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹23 Lakh and satisfied charges of ₹9 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressDeelwal Morh Distt Patiala, Punjab, India – 147001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nayan Pharmaceuticals Limited
The main business activity of Nayan Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nayan Pharmaceuticals Limited FY 2025 filings available
Nayan Pharmaceuticals Limited reported revenue of ₹81.6 Lakh (up 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Nayan Pharmaceuticals Limited
Revenue rose 16% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nayan Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹73,589 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.72 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nayan Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -4.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nayan Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nayan Pharmaceuticals Limited
Nayan Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gracia Lifesciences India Private Limited | ₹81.81 Lakh (FY 2025) | •••• | •••• | •••• | Chandigarh, India | |
| Inframed Lifesciences Private Limited | ₹81.77 Lakh (FY 2025) | •••• | •••• | 77.0% | •••• | Pune, Maharashtra, India |
| Ximing Labs Private Limited | ₹81.75 Lakh (FY 2024) | •••• | •••• | 32.0% | •••• | Palanpur, Gujarat, India |
| Kirat Lifesciences Private Limited | ₹81.69 Lakh (FY 2024) | •••• | •••• | -36.0% | •••• | Delhi, India |
| Pharmadeal Private Limited | ₹81.64 Lakh (FY 2021) | •••• | •••• | 213.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Nayan Pharmaceuticals Limited this company | ₹81.6 Lakh (FY 2024) | •••• | •••• | 16.0% | •••• | Patiala, Punjab, India |
| Ipzah Pharmaceuticals Private Limited | ₹81.39 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Patiala, Punjab, India |
| Hindustan Bio Sciences Limited Listed | ₹81.32 Lakh (FY 2025) | •••• | •••• | -23.0% | •••• | Hyderabad, Telangana, India |
| Lifeways Formulations Private Limited | ₹81.31 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Delhi, India |
| Medzone Pharmaceuticals Private Limited | ₹81.23 Lakh (FY 2024) | •••• | •••• | -24.0% | •••• | Puducherry, India |
| Rausd Pharma Private Limited | ₹81.2 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Darbhanga, Bihar, India |
Peers are the five companies nearest above and the five nearest below Nayan Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nayan Pharmaceuticals Limited
Nayan Pharmaceuticals Limited is audited by KANSAL VIKAS & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KANSAL VIKAS & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nayan Pharmaceuticals Limited
Nayan Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shiv Shankar Srivastava | Director | 26 Nov 1996 | 29 Years 10 Months | Current |
| Akshay Kumar Srivastava | Director | 16 Jul 2016 | 10 Years 2 Months | Current |
| Manohar Lal Verma | Director | 14 Dec 2022 | 3 Years 9 Months | Current |
Ownership and Shareholding of Nayan Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nayan Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2023 | Canara Bank | ₹16 Lakh | Open |
| 07 Jan 1998 | Canara Bank | ₹7 Lakh | Open |
| 13 Aug 2009 | Canara Bank | ₹5 Lakh | Satisfied |
| 07 Jan 1998 | Canara Bank | ₹4 Lakh | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Nayan Pharmaceuticals Limited
Employment history and EPFO contributions of people linked to Nayan Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Nayan Pharmaceuticals Limited
Nayan Pharmaceuticals has one previous CIN (Corporate Identification Number): L24231PB1996PLC019085. The current CIN is U24231PB1996PLC019085, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231PB1996PLC019085 | Current |
| L24231PB1996PLC019085 | Previous |
Recent Activity on Nayan Pharmaceuticals Limited
Nayan Pharmaceuticals Limited has 5 board changes on record since 1996: 3 appointments and 2 cessations. The latest: Manohar Lal Verma was appointed as Director on 14 Dec 2022.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Nayan Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nayan Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nayan Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nayan Pharmaceuticals Limited
Nayan Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AABCN2191F1ZW | Punjab | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nayan Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nayan Pharmaceuticals Limited
Nayan Pharmaceuticals is an active public limited company based in Patiala, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 November 1996 (30+ years old) and is registered under CIN U24231PB1996PLC019085.
Nayan Pharmaceuticals reported revenue of ₹81.6 Lakh for FY 2024 (up 16% YoY).
Nayan Pharmaceuticals has 3 current directors:
- Shiv Shankar Srivastava - Director
- Akshay Kumar Srivastava - Director
- Manohar Lal Verma - Director
Nayan Pharmaceuticals reported a net loss of ₹3.72 Lakh (net margin -4.6%) and EBITDA of -₹73,589 (EBITDA margin -0.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nayan Pharmaceuticals is 11% over three years and -6% over five years. In the latest year (FY 2024) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nayan Pharmaceuticals is 03AABCN2191F1ZW, registered in Punjab.
The CIN (Corporate Identification Number) of Nayan Pharmaceuticals is U24231PB1996PLC019085. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nayan Pharmaceuticals was incorporated on 26 November 1996, making it 30+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Nayan Pharmaceuticals by revenue are Gracia Lifesciences India Private Limited, Inframed Lifesciences Private Limited, Ximing Labs Private Limited, Kirat Lifesciences Private Limited, Pharmadeal Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Manohar Lal Verma was appointed as Director on 14 Dec 2022. Preet Kiran ceased to be Director on 14 Dec 2022. Tejinder Kaur Bedi ceased to be Director on 24 Mar 2017. Nayan Pharmaceuticals has 5 board changes on record in total.
The registered office of Nayan Pharmaceuticals is at Deelwal Morh Distt Patiala, Punjab, India – 147001.